Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and patient comfort influence confidence in adopting the higher-dose formulation.

Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...

An MG 2 electric vehicle is coming to showrooms as soon as 2027, according to the brand’s British arm, which said the automaker was spurred on by the success of the Renault 5 launched earlier this ...